semaglutide patent expiry india With semaglutide's expiring, generics are set to enter from soon, setting off competition in a fast-growing segment of obesity and diabetes care. https://timesofindia.indiatimes.com/toi-plus/business-economy/why-miracle-weight-loss-drugs-are Semaglutide Generics to Launch in

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics the effects of GLP-1, a hormone released after you eat, to control blood glucose levels and can help you lose weight

These proteins support muscle retention and keep hunger in check, making them a great fit for GLP-1 patients

This research provides confidence in the drug's potential

Cagrilintide and tirzepatide act on different hormone pathways

partly for this reason, some promising treatments are never approved, and many arrive too late for people who urgently need them

This article examines the evidence, potential risks, and alternative options for individuals with inflammatory bowel disease considering Ozempic, emphasising the importance of individualised assessment and multidisciplinary care involving both gastroenterology and diabetes specialists